{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:16:02Z","timestamp":1762161362896,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1057-3","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T07:43:52Z","timestamp":1529307832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical trials involving positron emission tomography and prostate cancer: an analysis of the ClinicalTrials.gov database"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1534-8520","authenticated-orcid":false,"given":"Nikola","family":"Cihoric","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Vlaskou Badra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Tsikkinis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Kroeze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Igrutinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branislav","family":"Jeremic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Zschaeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pirus","family":"Ghadjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"issue":"1","key":"1057_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1057_CR2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/jmri.23860","volume":"37","author":"JV Hegde","year":"2013","unstructured":"Hegde JV, Mulkern RV, Panych LP, Fennessy FM, Fedorov A, Maier SE, Tempany CM. Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging. 2013;37(5):1035\u201354.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"1057_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0090-4295(00)00896-7","volume":"57","author":"IJ Liu","year":"2001","unstructured":"Liu IJ, Zafar MB, Lai YH, Segall GM, Terris MK. Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology. 2001;57(1):108\u201311.","journal-title":"Urology"},{"issue":"6","key":"1057_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/02656736.2015.1040471","volume":"31","author":"N Cihoric","year":"2015","unstructured":"Cihoric N, Tsikkinis A, van Rhoon G, Crezee H, Aebersold DM, Bodis S, Beck M, Nadobny J, Budach V, Wust P, et al. Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. Int J Hyperth. 2015;31(6):609\u201314.","journal-title":"Int J Hyperth"},{"issue":"1","key":"1057_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-016-0740-5","volume":"12","author":"N Cihoric","year":"2017","unstructured":"Cihoric N, Tsikkinis A, Minniti G, Lagerwaard FJ, Herrlinger U, Mathier E, Soldatovic I, Jeremic B, Ghadjar P, Elicin O, et al. Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov. Radiat Oncol. 2017;12(1):1.","journal-title":"Radiat Oncol"},{"key":"1057_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13014-016-0624-8","volume":"11","author":"N Cihoric","year":"2016","unstructured":"Cihoric N, Tsikkinis A, Miguelez CG, Strnad V, Soldatovic I, Ghadjar P, Jeremic B, Dal Pra A, Aebersold DM, Lossl K. Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database. Radiat Oncol. 2016;11:48.","journal-title":"Radiat Oncol"},{"issue":"1","key":"1057_CR7","doi-asserted-by":"publisher","first-page":"S581","DOI":"10.1016\/j.ijrobp.2014.05.1750","volume":"90(","author":"N Cihoric","year":"2014","unstructured":"Cihoric N, Tsikkinis A, Aebersold D, L\u00f6ssl K, Zaugg K. Analysis of clinical trials in radiation oncology: a systematic characterization of the Clinicaltrials. Gov database. Int J Radiat Oncol Biol Phys. 2014;90((1):S581\u20132.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1057_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.euf.2015.05.003","volume":"1","author":"A Tsikkinis","year":"2015","unstructured":"Tsikkinis A, Cihoric N, Giannarini G, Hinz S, Briganti A, Wust P, Ost P, Ploussard G, Massard C, Surcel CI. Clinical perspectives from randomized phase 3 trials on prostate cancer: an analysis of the ClinicalTrials. Gov database. Eur Urol Focus. 2015;1(2):173\u201384.","journal-title":"Eur Urol Focus"},{"issue":"7","key":"1057_CR9","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1200\/JCO.2007.12.4487","volume":"26","author":"HI Scher","year":"2008","unstructured":"Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, et al. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the prostate cancer clinical trials working group. J Clin Oncol. 2008;26(7):1148\u201359.","journal-title":"J Clin Oncol"},{"issue":"11","key":"1057_CR10","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jamainternmed.2013.627","volume":"173","author":"BR Hirsch","year":"2013","unstructured":"Hirsch BR, Califf RM, Cheng SK, Tasneem A, Horton J, Chiswell K, Schulman KA, Dilts DM, Abernethy AP. Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov. JAMA Intern Med. 2013;173(11):972\u20139.","journal-title":"JAMA Intern Med"},{"issue":"17","key":"1057_CR11","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1001\/jama.2012.3424","volume":"307","author":"RM Califf","year":"2012","unstructured":"Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA. 2012;307(17):1838\u201347.","journal-title":"JAMA"},{"issue":"15","key":"1057_CR12","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","volume":"374","author":"H Mehanna","year":"2016","unstructured":"Mehanna H, Wong WL, McConkey CC, Rahman JK, Robinson M, Hartley AG, Nutting C, Powell N, Al-Booz H, Robinson M, et al. PET-CT surveillance versus neck dissection in advanced head and neck Cancer. N Engl J Med. 2016;374(15):1444\u201354.","journal-title":"N Engl J Med"},{"issue":"10","key":"1057_CR13","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jamaoncol.2017.0982","volume":"3","author":"FM Kong","year":"2017","unstructured":"Kong FM, Ten Haken RK, Schipper M, Frey KA, Hayman J, Gross M, Ramnath N, Hassan KA, Matuszak M, Ritter T, et al. Effect of Midtreatment PET\/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non-small-cell lung Cancer: a phase 2 clinical trial. JAMA Oncol. 2017;3(10):1358\u201365.","journal-title":"JAMA Oncol"},{"issue":"27","key":"1057_CR14","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on malignant lymphomas imaging working group. J Clin Oncol. 2014;32(27):3048\u201358.","journal-title":"J Clin Oncol"},{"issue":"27","key":"1057_CR15","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, Alliance AL, Lymphoma G, Eastern Cooperative Oncology G, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059\u201368.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1057_CR16","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.juro.2013.10.065","volume":"191","author":"DM Schuster","year":"2014","unstructured":"Schuster DM, Nieh PT, Jani AB, Amzat R, Bowman FD, Halkar RK, Master VA, Nye JA, Odewole OA, Osunkoya AO, et al. Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)in-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial. J Urol. 2014;191(5):1446\u201353.","journal-title":"J Urol"},{"issue":"9","key":"1057_CR17","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00259-016-3329-1","volume":"43","author":"C Nanni","year":"2016","unstructured":"Nanni C, Zanoni L, Pultrone C, Schiavina R, Brunocilla E, Lodi F, Malizia C, Ferrari M, Rigatti P, Fonti C, et al. (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET\/CT in prostate cancer relapse: results of a prospective trial. Eur J Nucl Med Mol Imaging. 2016;43(9):1601\u201310.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"22","key":"1057_CR18","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMp0706892","volume":"357","author":"J Avorn","year":"2007","unstructured":"Avorn J. In defense of pharmacoepidemiology--embracing the yin and yang of drug research. N Engl J Med. 2007;357(22):2219\u201321.","journal-title":"N Engl J Med"},{"issue":"15","key":"1057_CR19","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1503\/cmaj.092252","volume":"182","author":"RJ Williams","year":"2010","unstructured":"Williams RJ, Tse T, Harlan WR, Zarin DA. Registration of observational studies: is it time? CMAJ. 2010;182(15):1638\u201342.","journal-title":"CMAJ"},{"issue":"Suppl 1","key":"1057_CR20","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.2105\/AJPH.2005.081711","volume":"97","author":"BC Choi","year":"2007","unstructured":"Choi BC, Frank J, Mindell JS, Orlova A, Lin V, Vaillancourt AD, Puska P, Pang T, Skinner HA, Marsh M, et al. Vision for a global registry of anticipated public health studies. Am J Public Health. 2007;97(Suppl 1):S82\u20137.","journal-title":"Am J Public Health"},{"issue":"1","key":"1057_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.radonc.2011.07.012","volume":"100","author":"R Potter","year":"2011","unstructured":"Potter R, Georg P, Dimopoulos JC, Grimm M, Berger D, Nesvacil N, Georg D, Schmid MP, Reinthaller A, Sturdza A, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol. 2011;100(1):116\u201323.","journal-title":"Radiother Oncol"},{"key":"1057_CR22","unstructured":"Bourne P, Clark T, Dale R, de Waard A, Herman I, Hovy E, Shotton D. FORCE11 MANIFESTO. FORCE11: The Future of Research Communications and e-Scholarship \n                    https:\/\/www.force11.org\/about\/manifesto"},{"key":"1057_CR23","volume-title":"Force11","author":"P Bourne","year":"2012","unstructured":"Bourne P, Clark T, Dale R, de Waard A, Herman I, Hovy E, Shotton D. Improving the future of research communication and e-scholarship (Force11 white paper). In: Force11; 2012."}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1057-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1057-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1057-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T19:27:21Z","timestamp":1560799641000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1057-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1057"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1057-3","relation":{},"ISSN":["1748-717X"],"issn-type":[{"type":"electronic","value":"1748-717X"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"assertion":[{"value":"6 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"113"}}